Another aspect is that our RRMS patients were in the remitting phase, and the levels of some cytokines, such as IL-10 and IFN-γ, were increased in this phase, while others, such as IL-4 and IL-17, were decreased in previous studies. The gene discussed is IL4; the disease is relapsing-remitting multiple sclerosis.